Environmental

Product Energy Efficiency: Varex Imaging's core business in X-ray imaging components faces moderate environmental risk due to the energy intensity of medical imaging equipment, but the company has made incremental improvements in product energy efficiency relative to legacy peers.

Manufacturing Footprint: Varex operates manufacturing facilities in the US, Europe, and Asia, with limited public disclosure on emissions or waste reduction targets, placing it behind best-in-class medtech peers on transparency and environmental management.

Regulatory Exposure: The company is subject to environmental regulations regarding hazardous materials (e.g., RoHS, REACH), but has not reported material violations or fines, indicating basic compliance but limited leadership in sustainability.

Varex Imaging demonstrates basic compliance with environmental regulations and some product efficiency improvements, but lacks robust disclosure and clear sustainability targets, resulting in a moderate environmental risk profile.

Social

Workforce Safety and Retention: Varex reports a stable workforce with no recent material safety incidents, and its stock-based compensation to revenue ratio (1.3%) is in line with industry norms, supporting talent retention.

Product Quality and Patient Safety: As a supplier of critical medical imaging components, Varex faces high product quality and safety expectations; there have been no major recalls or regulatory actions in the past year, indicating effective quality controls.

Community and Stakeholder Engagement: The company provides limited disclosure on community engagement or diversity initiatives, lagging leading medtech peers in social transparency and stakeholder programs.

Varex maintains a solid record on workforce safety and product quality, but its limited social disclosure and stakeholder engagement keep its social profile moderate relative to peers.

Governance

Board Independence and Oversight: Varex's board is majority independent and includes directors with relevant industry and financial expertise, supporting effective oversight.

Capital Discipline: The company maintains a low debt-to-equity ratio (0.75), reflecting prudent capital management, though its net debt to EBITDA remains elevated at 3.16x due to recent earnings volatility.

Disclosure and Compliance: Varex is current with SEC filings and has not reported material governance controversies or regulatory actions, but its ESG disclosure lags best-in-class medtech peers.

Varex demonstrates sound board structure and capital discipline, but its limited ESG disclosure and elevated leverage metrics constrain its governance score to the moderate range.

Overall Score

Varex Imaging's ESG profile is moderate across all pillars. The company shows basic compliance and risk controls but lacks robust disclosure and leadership on key ESG issues, keeping it in line with, but not ahead of, most medtech peers.